Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

Dániel Bereczki, Emõke Nagy, András Pál, Mária T. Magyar, József Balla, Gavin J. Blake, Robert J. Ostfeld, E. Kent Yucel, Nerea Varo, Uwe Schonbeck, Michael A. Blake, Marie Gerhard, Paul M. Ridker, Peter Libby, Richard T. Lee

Research output: Letter

29 Citations (Scopus)
Original languageEnglish
Pages (from-to)1129-1131
Number of pages3
JournalArteriosclerosis, thrombosis, and vascular biology
Volume23
Issue number6
DOIs
Publication statusPublished - jún. 1 2003

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bereczki, D., Nagy, E., Pál, A., Magyar, M. T., Balla, J., Blake, G. J., Ostfeld, R. J., Yucel, E. K., Varo, N., Schonbeck, U., Blake, M. A., Gerhard, M., Ridker, P. M., Libby, P., & Lee, R. T. (2003). Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters). Arteriosclerosis, thrombosis, and vascular biology, 23(6), 1129-1131. https://doi.org/10.1161/01.ATV.0000072368.37740.8E